Schwartz PE - Search Results

1

Financial toxicity in patients with gynecologic malignancies: a cross sectional study.

Zeybek B, Webster E, Pogosian N, Tymon-Rosario J, Balch A, Altwerger G, Clark M, Menderes G, Huang G, Azodi M, Ratner ES, Schwartz PE, Santin AD, Andikyan V. Zeybek B, et al. Among authors: schwartz pe. J Gynecol Oncol. 2021 Nov;32(6):e87. doi: 10.3802/jgo.2021.32.e87. Epub 2021 Jul 23. J Gynecol Oncol. 2021. PMID: 34431257 Free PMC article.

2

Ovarian cancer staging: does it require a gynecologic oncologist?

Mayer AR, Chambers SK, Graves E, Holm C, Tseng PC, Nelson BE, Schwartz PE. Mayer AR, et al. Among authors: schwartz pe. Gynecol Oncol. 1992 Nov;47(2):223-7. doi: 10.1016/0090-8258(92)90110-5. Gynecol Oncol. 1992. PMID: 1468701 Free article.

3

Correlation between measured creatinine clearance and calculated creatinine clearance in ovarian cancer patients.

Chambers JT, Chambers SK, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Jan;36(1):66-8. doi: 10.1016/0090-8258(90)90110-7. Gynecol Oncol. 1990. PMID: 2295454

4

Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.

Nam JH, Cole LA, Chambers JT, Schwartz PE. Nam JH, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Mar;36(3):383-90. doi: 10.1016/0090-8258(90)90148-e. Gynecol Oncol. 1990. PMID: 2318449

5

Urinary gonadotropin fragment, a new tumor marker. II. Differentiating a benign from a malignant pelvic mass.

Cole LA, Nam JH, Chambers JT, Schwartz PE. Cole LA, et al. Among authors: schwartz pe. Gynecol Oncol. 1990 Mar;36(3):391-4. doi: 10.1016/0090-8258(90)90149-f. Gynecol Oncol. 1990. PMID: 2318450

6

Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.

Chambers SK, Flynn SD, Del Prete SA, Chambers JT, Schwartz PE. Chambers SK, et al. Among authors: schwartz pe. Gynecol Oncol. 1989 Mar;32(3):303-9. doi: 10.1016/0090-8258(89)90629-x. Gynecol Oncol. 1989. PMID: 2465939

7

Estrogen and progestin receptor levels as prognosticators for survival in endometrial cancer.

Chambers JT, MacLusky N, Eisenfield A, Kohorn EI, Lawrence R, Schwartz PE. Chambers JT, et al. Among authors: schwartz pe. Gynecol Oncol. 1988 Sep;31(1):65-81. doi: 10.1016/0090-8258(88)90270-3. Gynecol Oncol. 1988. PMID: 3410357

8

Urinary gonadotropin fragments (UGF) in cancers of the female reproductive system. II. Initial serial studies.

Wang YX, Schwartz PE, Chambers JT, Cole LA. Wang YX, et al. Among authors: schwartz pe. Gynecol Oncol. 1988 Sep;31(1):91-102. doi: 10.1016/0090-8258(88)90274-0. Gynecol Oncol. 1988. PMID: 3410359

9

A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus.

Resnik E, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Resnik E, et al. Among authors: schwartz pe. Gynecol Oncol. 1995 Mar;56(3):370-5. doi: 10.1006/gyno.1995.1065. Gynecol Oncol. 1995. PMID: 7705670 Free article. Clinical Trial.

10

Effect of combination chemotherapy with cisplatin and cyclophosphamide on human immunodeficiency virus type-1 surrogate markers in a patient with advanced epithelial ovarian cancer.

Fishman DA, Viscarello RR, Cass I, Schwartz PE. Fishman DA, et al. Among authors: schwartz pe. Gynecol Oncol. 1995 Apr;57(1):105-8. doi: 10.1006/gyno.1995.1105. Gynecol Oncol. 1995. PMID: 7705691 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters